MARKET

MTEM

MTEM

Molecular US
NASDAQ

Real-time Quotes | Nasdaq Last Sale

13.95
+0.11
+0.79%
After Hours: 13.95 0 0.00% 16:00 04/07 EDT
OPEN
14.21
PREV CLOSE
13.84
HIGH
14.50
LOW
13.74
VOLUME
157.65K
TURNOVER
--
52 WEEK HIGH
19.12
52 WEEK LOW
4.510
MARKET CAP
636.79M
P/E (TTM)
-7.5712
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average MTEM stock price target is 22.00 with a high estimate of 39.00 and a low estimate of 16.00.

EPS

MTEM News

More
  • DZ Bank likes Medtronic in premarket analyst action
  • Seeking Alpha - Article · 03/25 11:14
  • Molecular Templates (MTEM) Investor Presentation - Slideshow
  • Seeking Alpha - Article · 03/17 21:17
  • 7 Great Stocks for a Small Budget
  • Zacks · 03/13 19:30
  • Molecular Templates EPS misses by $0.19, beats on revenue
  • seekingalpha · 03/13 01:50

Industry

Biotechnology & Medical Research
-2.89%
Pharmaceuticals & Medical Research
-0.82%

Hot Stocks

Symbol
Price
%Change

About MTEM

Molecular Templates, Inc., formerly Threshold Pharmaceuticals, Inc., is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of therapeutic and diagnostic agents that selectively target tumor cells for the treatment of patients living with cancer. The Company also focused on the discovery, development, and commercialization of immunotoxins called engineered toxin bodies (ETBs). The Company is developing two therapeutic product candidates based on hypoxia-activated prodrug technology: evofosfamide and tarloxotinib. The Company’s lead drug candidate MT-3724 is an is an immunotoxin that targets the CD20 cell surface antigen present in a variety of lymphomas and leukemias.
More

Webull offers kinds of Molecular Templates Inc stock information, including NASDAQ:MTEM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MTEM stock news, and many more online research tools to help you make informed decisions.